Dichotomy between postprandial glucose and lipid profiles in adults with cystic fibrosis: A pilot study

Journal of Cystic Fibrosis

Volumn 8, Issue 2, 2009, Pages 128-134

  Hammana, I ^a   Coderre, L ^a   Potvin, S ^a,c   Costa, M ^a   Berthiaume, Y ^a,c   Lavoie, A ^a,c   Chiasson, J L ^a   Levy, E ^a,d   Rabasa Lhoret, R ^a,b,c,d  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Montreal Diabetes Research Centre   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Cystic fibrosis; Diabetes; Insulin; Lipid metabolism; Meal test

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN; LIPID; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; INSULIN BLOOD LEVEL; LIPID DIET; LIPID METABOLISM; MALE; ORAL GLUCOSE TOLERANCE TEST; PILOT STUDY; POSTPRANDIAL STATE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 60749103589     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2008.11.002     Document Type: Article

References (33)

1. Costa M., Potvin S., Berthiaume Y., Gauthier L., Jeanneret A., Lavoie A., et al. Diabetes: a major co-morbidity of cystic fibrosis. Diabetes Metab 31 3 Pt 1 (2005) 221-232
2. Hardin D.S., and Moran A. Diabetes mellitus in cystic fibrosis. Endocrinol Metab Clin N Am 28 4 (1999) 787-800 ix
3. Costa M., Potvin S., Hammana I., Malet A., Berthiaume Y., Jeanneret A., et al. Increased glucose excursion in cystic fibrosis and its association with a worse clinical status. J Cyst Fibros 6 6 (2007) 376-383
4. Carpentier A.C., Frisch F., Brassard P., Lavoie F., Bourbonnais A., Cyr D., et al. Mechanism of insulin-stimulated clearance of plasma nonesterified fatty acids in humans. Am J Physiol Endocrinol Metab 292 3 (2007) E693-E701
5. Pencharz P.B., and Durie P.R. Nutritional management of cystic fibrosis. Annu Rev Nutr 13 (1993) 111-136
6. Roy C.C., Weber A.M., Morin C.L., Combes J.C., Nussle D., Megevand A., et al. Abnormal biliary lipid composition in cystic fibrosis. Effect of pancreatic enzymes. N Engl J Med 297 24 (1977) 1301-1305
7. Littlewood J.M., and MacDonald A. Rationale of modern dietary recommendations in cystic fibrosis. J R Soc Med 80 Suppl 15 (1987) 16-24
8. Cystic Fibrosis Foundation. Microbiology and infectious disease in cystic fibrosis (1994), Bethesda 1-26
9. Stallings V.A., Stark L.J., Robinson K.A., Feranchak A.P., and Quinton H. Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. J Am Diet Assoc 108 5 (2008) 832-839
10. Diagnosis and classification of diabetes mellitus. Diabetes Care 28 Suppl 1 (2005) S37-S42
11. Moran A., Phillips J., and Milla C. Insulin and glucose excursion following premeal insulin lispro or repaglinide in cystic fibrosis-related diabetes. Diabetes Care 24 10 (2001) 1706-1710
12. Wolever T.M., Chiasson J.L., Csima A., Hunt J.A., Palmason C., Ross S.A., et al. Variation of postprandial plasma glucose, palatability, and symptoms associated with a standardized mixed test meal versus 75 g oral glucose. Diabetes Care 21 3 (1998) 336-340
13. Horowitz M., Harding P.E., Maddox A.F., Wishart J.M., Akkermans L.M., Chatterton B.E., et al. Gastric and oesophageal emptying in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 32 3 (1989) 151-159
14. Bodet-Milin C., Querellou S., Oudoux A., Haloun A., Horeau-Llanglard D., Carlier T., et al. Delayed gastric emptying scintigraphy in cystic fibrosis patients before and after lung transplantation. J Heart Lung Transplant 25 9 (2006) 1077-1083
15. Bentur L., Hino B., Shamir R., Elias N., Hartman C., Eshach-Adiv O., et al. Impaired gastric myolectrical activity in patients with cystic fibrosis. J Cystic Fibros 5 3 (2006) 187-191
16. Collins C.E., Francis J.L., Thomas P., Henry R.L., and O'Loughlin E.V. Gastric emptying time is faster in cystic fibrosis. J Pediatr Gastroenterol Nutr 25 5 (1997) 492-498
17. Vollmer K., Holst J.J., Baller B., Ellrichmann M., Nauck M.A., Schmidt W.E., et al. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance. Diabetes 57 3 (2008) 678-687
18. Lanng S., Thorsteinsson B., Roder M.E., Orskov C., Holst J.J., Nerup J., et al. Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance. Acta Endocrinol (Copenh) 128 3 (1993) 207-214
19. Brindisi M.C., Rabasa-Lhoret R., and Chiasson J.L. Postprandial hyperglycaemia: to treat or not to treat?. Diabetes Metab 32 2 (2006) 105-111
20. Dunning B.E., and Gerich J.E. The role of alpha-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications. Endocr Rev 28 3 (2007) 253-283
21. Hardin D.S., Ahn C., Rice J., Rice M., and Rosenblatt R. Elevated gluconeogenesis and lack of suppression by insulin contribute to cystic fibrosis-related diabetes. J Investig Med 56 3 (2008) 567-573
22. Hardin D.S., LeBlanc A., Para L., and Seilheimer D.K. Hepatic insulin resistance and defects in substrate utilization in cystic fibrosis. Diabetes 48 5 (1999) 1082-1087
23. Hinds A., Sheehan A.G., Machida H., and Parsons H.G. Postprandial hyperglycemia and pancreatic function in cystic fibrosis patients. Diabetes Res 18 2 (1991) 69-78
24. Dobson L., Sheldon C.D., and Hattersley A.T. Conventional measures underestimate glycaemia in cystic fibrosis patients. Diabet Med 21 7 (2004) 691-696
25. Brindisi M.C., Hahn J., Chiasson J.L., and Rabasa-Lhoret R. Under-utilization of capillary glucose monitoring by type 2 diabetic patients. Diabetes Res Clin Pract 75 1 (2007) 123-125
26. Solomon M.P., Wilson D.C., Corey M., Kalnins D., Zielenski J., Tsui L.C., et al. Glucose intolerance in children with cystic fibrosis. J Pediatr 142 2 (2003) 128-132
27. Moreau F., Weiller M.A., Rosner V., Weiss L., Hasselmann M., Pinget M., et al. Continuous glucose monitoring in cystic fibrosis patients according to the glucose tolerance. Horm Metab Res 40 7 (2008) 502-506
28. Figueroa V., Milla C., Parks E.J., Schwarzenberg S.J., and Moran A. Abnormal lipid concentrations in cystic fibrosis. Am J Clin Nutr 75 6 (2002) 1005-1011
29. Carlson O.D., David J.D., Schrieder J.M., Muller D.C., Jang H.J., Kim B.J., et al. Contribution of nonesterified fatty acids to insulin resistance in the elderly with normal fasting but diabetic 2 h postchallenge plasma glucose levels: the Baltimore Longitudinal Study of Aging. Metabolism 56 10 (2007) 1444-1451
30. Moran A., Basu R., Milla C., and Jensen M.D. Insulin regulation of free fatty acid kinetics in adult cystic fibrosis patients with impaired glucose tolerance. Metabolism 53 11 (2004) 1467-1472
31. Robertson R.P., Harmon J., Tran P.O., and Poitout V. Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 53 Suppl 1 (2004) S119-S124
32. Carpentier A.C. Postprandial fatty acid metabolism in the development of lipotoxicity and type 2 diabetes. Diabetes Metab 34 2 (2008) 97-107
33. Rafii M., Chapman K., Stewart C., Kelly E., Hanna A., Wilson D.C., et al. Changes in response to insulin and the effects of varying glucose tolerance on whole-body protein metabolism in patients with cystic fibrosis. Am J Clin Nutr 81 2 (2005) 421-426